Literature DB >> 7994414

Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: a preliminary report.

W P Yu1, T M Chang.   

Abstract

We used biodegradable polymers like polylactic acid, poly-isobutylcyanoacrylate and others to prepare nanocapsules containing hemoglobin. We prepared the optimal mean diameters of between 0.08 to 0.12 micron (80-120 nm). They are spherical and homogeneous. The membrane thickness is 0.005-0.015 micron (5-15nm). With different formulation, the hemoglobin contents in the particles may be varied from 30-45%. Phospholipid is not required in bovine hemoglobin. It is required for human hemoglobin in order to retain cofactors required for optimal P50. The P50 of the biodegradable polymer membrane containing bovine hemoglobin was between 27-29 mmHg. This is the same P50 as bovine hemoglobin used in the preparation. Thus the procedure of preparation did not damage hemoglobin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7994414     DOI: 10.3109/10731199409117926

Source DB:  PubMed          Journal:  Artif Cells Blood Substit Immobil Biotechnol        ISSN: 1073-1199


  10 in total

Review 1.  Nanobiotechnology for hemoglobin-based blood substitutes.

Authors:  T M S Chang
Journal:  Crit Care Clin       Date:  2009-04       Impact factor: 3.598

2.  Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.

Authors:  Thomas Ming Swi Chang
Journal:  Biochim Biophys Acta       Date:  2008-06-17

Review 3.  Blood substitutes: possibilities with nanotechnology.

Authors:  Feroz Alam; Neha Yadav; Murad Ahmad; Mariyam Shadan
Journal:  Indian J Hematol Blood Transfus       Date:  2013-12-10       Impact factor: 0.900

Review 4.  Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules.

Authors:  Thomas Ming Swi Chang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010 Jul-Aug

5.  Long-term effects on the histology and function of livers and spleens in rats after 33% toploading of PEG-PLA-nano artificial red blood cells.

Authors:  Zun Chang Liu; Thomas M S Chang
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2008-12-09

6.  Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase.

Authors:  Wei Gao; Yuzhu Bian; Thomas M S Chang
Journal:  Artif Cells Nanomed Biotechnol       Date:  2013-01-22       Impact factor: 5.678

7.  Effects of PEG-PLA-nano artificial cells containing hemoglobin on kidney function and renal histology in rats.

Authors:  Zun Chang Liu; Thomas M S Chang
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2008

8.  In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content.

Authors:  Yan Sheng; Yuan Yuan; Changsheng Liu; Xinyi Tao; Xiaoqian Shan; Feng Xu
Journal:  J Mater Sci Mater Med       Date:  2009-04-14       Impact factor: 3.896

9.  PEG-PLA Nanocapsules Containing a Nanobiotechnological Complex of Polyhemoglobin-Tyrosinase for the Depletion of Tyrosine in Melanoma: Preparation and In Vitro Characterisation.

Authors:  Caroline Fustier; Thomas M S Chang
Journal:  J Nanomedine Biotherapeutic Discov       Date:  2012-03

10.  Nanobiotechnological Nanocapsules Containing Polyhemoglobin-Tyrosinase: Effects on Murine B16F10 Melanoma Cell Proliferation and Attachment.

Authors:  Yun Wang; Thomas M S Chang
Journal:  J Skin Cancer       Date:  2012-11-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.